LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

BAILLIE GIFFORD & CO's Holding History (CIK: 0001088875)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 141,949 Value ($000) $196 Avg Close — Range —
Q2 2024
Shares 519,998 Value ($000) $754 Avg Close — Range —
Q1 2024
Shares 656,157 Value ($000) $1,463 Avg Close — Range —
Q4 2023
Shares 690,871 Value ($000) $1,340 Avg Close — Range —
Q3 2023
Shares 732,636 Value ($000) $1,077 Avg Close — Range —
Q2 2023
Shares 761,321 Value ($000) $2,421 Avg Close — Range —
Q1 2023
Shares 761,321 Value ($000) $1,797 Avg Close — Range —
Q4 2022
Shares 761,321 Value ($000) $2,642 Avg Close — Range —
Q3 2022
Shares 755,105 Value ($000) $5,535 Avg Close — Range —
Q2 2022
Shares 707,665 Value ($000) $4,615 Avg Close — Range —
Q1 2022
Shares 784,741 Value ($000) $3,963 Avg Close — Range —
Q4 2021
Shares 723,370 Value ($000) $5,599 Avg Close — Range —
Q3 2021
Shares 427,483 Value ($000) $6,327 Avg Close — Range —
Q2 2021
Shares 258,823 Value ($000) $4,204 Avg Close — Range —